Immunoglobulins are antibodies created and used by your body to destroy invaders such as viruses and bacteria.‌ M-proteins in your urine can be a sign of serious health problems, such as ...

A 50-year-old man dies due to a rabies like illness called ABLV, after getting bitten by a bat several months ago.

Immunoglobulin A nephropathy (IgAN), also called Berger's disease, is an autoimmune disease that damages your kidneys. This condition happens when antibodies (specifically IgA) build up and form ...

The immunoglobulin A IgA vasculitis market size has shown solid growth in recent years, escalating from $1.53 billion in 2024 to $1.63 billion in 2025, indicating a compound annual growth rate CAGR of ...

What to Know About High Immunoglobulin (IgE) Levels. Story by Pat Bass, MD • 1y. Symptoms, Causes, and Whether Certain Levels Are Dangerous. Medically reviewed by Susan Russell, MD.

The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA), through the Executive Steering Group on ...

In patients with inborn errors of immunity who are prone to viral infections, immunoglobulin replacement therapy (IRT) administered via the conventional subcutaneous route showed lower viral infection ...

Thursday 5th June, 2025 The Health Ministry is in the news for the wrong reasons again. Its decision to resume the use of a stock of immunoglobulin, withdrawn from the government hospitals last year ...

A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin eye drop for the treatment of dry eye disease, according to a press ...

The responses of the major immunoglobulins (gamma G, gamma M and gamma A) in serum and nasal and duodenal secretions were studied in infants and children after immunization with live and inactivate ...

Otsuka Pharmaceutical Development & Commercialization, Inc.Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN). Clinicaltrials.gov. 6. Cheung CK, Barratt J, Liew ...